Denkapparat Operations Gmb H Ultragenyx Pharmaceutical Inc. Transaction History
Denkapparat Operations Gmb H
- $94.5 Billion
- Q1 2025
A detailed history of Denkapparat Operations Gmb H transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Denkapparat Operations Gmb H holds 6,892 shares of RARE stock, worth $187,048. This represents 0.26% of its overall portfolio holdings.
Number of Shares
6,892
Previous 4,912
40.31%
Holding current value
$187,048
Previous $207 Million
20.77%
% of portfolio
0.26%
Previous 0.31%
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
89.4MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$271 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$152 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$113 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$87.4 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$71.1 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.9B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...